{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,9,17]],"date-time":"2026-09-17T07:01:29Z","timestamp":1789628489186,"version":"build-2803163510"},"reference-count":41,"publisher":"Oxford University Press (OUP)","issue":"4","content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["Am J Clin Pathol"],"published-print":{"date-parts":[[2007,4]]},"DOI":"10.1309\/nuqhj79bhwyd9taf","type":"journal-article","created":{"date-parts":[[2007,3,30]],"date-time":"2007-03-30T20:20:34Z","timestamp":1175286034000},"page":"633-641","source":"Crossref","is-referenced-by-count":50,"title":["Malignant B Cells From Patients With Primary Central Nervous System Lymphoma Express Stromal Cell\u2013Derived Factor-1"],"prefix":"10.1093","volume":"127","author":[{"given":"Justine R.","family":"Smith","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Katherine M.","family":"Falkenhagen","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Sarah E.","family":"Coupland","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Timothy J.","family":"Chipps","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"James T.","family":"Rosenbaum","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Rita M.","family":"Braziel","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"286","published-online":{"date-parts":[[2007,4,1]]},"reference":[{"key":"E00001","unstructured":"Freilich RJ, DeAngelis LM. Primary central nervous system lymphoma. <i>Neural Clin.<\/i> 1995; 13:901-914."},{"key":"E00002","unstructured":"Nagasawa T, Kikutani H, Kishimoto T. Molecular cloning and structure of a pre-B-cell growth-stimulating factor. <i>Proc Natl Acad Sci USA.<\/i> 1994; 91:2305-2309."},{"key":"E00003","unstructured":"Burger JA, Tsukada N, Burger M, et al. Blood-derived nurse-like cells protect chronic lymphocytic leukemia B cells from spontaneous apoptosis through stromal cell-derived factor-1. <i>Blood.<\/i> 2000; 96:2655-2663."},{"key":"E00004","unstructured":"Butler JM, Guthrie SM, Koc M, et al. SDF-1 is both necessary and sufficient to promote proliferative retinopathy. <i>J Clin Invest.<\/i> 2005; 115:86-93."},{"key":"E00005","unstructured":"Bertolini F, Dell'Agnola C, Mancuso P, et al. CXCR4 neutralization, a novel therapeutic approach for non-Hodgkin's lymphoma. <i>Cancer Res.<\/i> 2002; 62:3106-3112."},{"key":"E00006","doi-asserted-by":"crossref","unstructured":"Plotkin SR. Update on primary central nervous system lymphoma. <i>Curr Opin Neurol.<\/i> 2005; 18:645-653.","DOI":"10.1097\/01.wco.0000194142.94546.60"},{"key":"E00007","unstructured":"Chan CC, Wallace DJ. Intraocular lymphoma: update on diagnosis and management. <i>Cancer Control.<\/i> 2004; 11:285-295."},{"key":"E00008","unstructured":"Olson JE, Janney CA, Rao RD, et al. The continuing increase in the incidence of primary central nervous system non-Hodgkin lymphoma: a Surveillance, Epidemiology, and End Results analysis. <i>Cancer.<\/i> 2002; 95:1504-1510."},{"key":"E00009","unstructured":"Diamond C, Taylor TH, Aboumrad T, et al. Changes in acquired immunodeficiency syndrome-related non-Hodgkin lymphoma in the era of highly active antiretroviral therapy: incidence, presentation, treatment, and survival. <i>Cancer.<\/i> 2006; 106:128-135."},{"key":"E00010","doi-asserted-by":"crossref","unstructured":"Shah GD, DeAngelis LM. Treatment of primary central nervous system lymphoma. <i>Hematol Oncol Clin North Am.<\/i> 2005; 19:611-627, v.","DOI":"10.1016\/j.hoc.2005.05.002"},{"key":"E00011","unstructured":"McAllister LD, Doolittle ND, Guastadisegni PE, et al. Cognitive outcomes and long-term follow-up results after enhanced chemotherapy delivery for primary central nervous system lymphoma. <i>Neurosurgery.<\/i> 2000; 46:51-61."},{"key":"E00012","unstructured":"Wong ET, Tishler R, Barren L, et al. Immunochemotherapy with rituximab and temozolomide for central nervous system lymphomas. <i>Cancer.<\/i> 2004; 101:139-145."},{"key":"E00013","unstructured":"Enting RH, Demopoulos A, DeAngelis LM, et al. Salvage therapy for primary CNS lymphoma with a combination of rituximab and temozolomide. <i>Neurology.<\/i> 2004; 63:901-903."},{"key":"E00014","unstructured":"Kakinuma T, Hwang ST. Chemokines, chemokine receptors, and cancer metastasis. <i>J Leukoc Biol.<\/i> 2006; 79:639-651."},{"key":"E00015","unstructured":"Hochberg FH, Miller DC. Primary central nervous system lymphoma. <i>J Neurosurg.<\/i> 1988; 68:835-853."},{"key":"E00016","doi-asserted-by":"crossref","unstructured":"Von Andrian UH. Introduction: chemokines: regulation of immune cell trafficking and lymphoid organ architecture. <i>Semin Immunol.<\/i> 2003; 15:239-241.","DOI":"10.1016\/j.smim.2003.08.001"},{"key":"E00017","unstructured":"Smith JR, Braziel RM, Paoletti S, et al. Expression of B-cell-attracting chemokine 1 (CXCL13) by malignant lymphocytes and vascular endothelium in primary central nervous system lymphoma. <i>Blood.<\/i> 2003; 101:815-821."},{"key":"E00018","unstructured":"Casamayor-Palleja M, Mondiere P, Amara A, et al. Expression of macrophage inflammatory protein-3alpha, stromal cell-derived factor-1, and B-cell-attracting chemokine-1 identifies the tonsil crypt as an attractive site for B cells. <i>Blood.<\/i> 2001; 97:3992-3994."},{"key":"E00019","unstructured":"Page G, Miossec P. Paired synovium and lymph nodes from rheumatoid arthritis patients differ in dendritic cell and chemokine expression. <i>J Pathol.<\/i> 2004; 204:28-38."},{"key":"E00020","unstructured":"Allen CD, Ansel KM, Low C, et al. Germinal center dark and light zone organization is mediated by CXCR4 and CXCR5. <i>Nat Immunol.<\/i> 2004; 5:943-952."},{"key":"E00021","unstructured":"Bleul CC, Fuhlbrigge RC, Casasnovas JM, et al. A highly efficacious lymphocyte chemoattractant, stromal cell-derived factor 1 (SDF-1). <i>J Exp Med.<\/i> 1996; 184:1101-1109."},{"key":"E00022","unstructured":"Lazarini F, Tham TN, Casanova P, et al. Role of the alpha-chemokine stromal cell-derived factor (SDF-1) in the developing and mature central nervous system. <i>Glia.<\/i> 2003; 42:139-148."},{"key":"E00023","unstructured":"Jaffe ES, Harris NL, Stein H, et al, eds. Pathology and Genetics of Tumours of Haemopoietic and Lymphoid Tissues. Lyon, France: IARC Press; 2001. <i>World Health Organization Classification of Tumours.<\/i>"},{"key":"E00024","unstructured":"Burger JA, Kipps TJ. CXCR4: a key receptor in the crosstalk between tumor cells and their microenvironment. <i>Blood.<\/i> 2006; 107:1761-1767."},{"key":"E00025","unstructured":"Chan CC, Shen D, Hackett JJ, et al. Expression of chemokine receptors, CXCR4 and CXCR5, and chemokines, BLC and SDF-1, in the eyes of patients with primary intraocular lymphoma. <i>Ophthalmology.<\/i> 2003; 110:421-426."},{"key":"E00026","doi-asserted-by":"crossref","unstructured":"Murdoch C. CXCR4: chemokine receptor extraordinaire. <i>Immunol Rev.<\/i> 2000; 177:175-184.","DOI":"10.1034\/j.1600-065X.2000.17715.x"},{"key":"E00027","unstructured":"Klein RS, Rubin JB. Immune and nervous system CXCL12 and CXCR4: parallel roles in patterning and plasticity. <i>Trends Immunol.<\/i> 2004; 25:306-314."},{"key":"E00028","unstructured":"Pashenkov M, Soderstrom M, Link H. Secondary lymphoid organ chemokines are elevated in the cerebrospinal fluid during central nervous system inflammation. <i>J Neuroimmunol.<\/i> 2003; 135:154-160."},{"key":"E00029","unstructured":"Giunti D, Borsellino G, Benelli R, et al. Phenotypic and functional analysis of T cells homing into the CSF of subjects with inflammatory diseases of the CNS. <i>J Leukoc Biol.<\/i> 2003; 73:584-590."},{"key":"E00030","unstructured":"Corcione A, Casazza S, Ferretti E, et al. Recapitulation of B cell differentiation in the central nervous system of patients with multiple sclerosis. <i>Proc Natl Acad Sci U S A.<\/i> 2004; 101:11064-11069."},{"key":"E00031","unstructured":"Ambrosini E, Remoli ME, Giacomini E, et al. Astrocytes produce dendritic cell-attracting chemokines in vitro and in multiple sclerosis lesions. <i>J Neuropathol Exp Neurol.<\/i> 2005; 64:706-715."},{"key":"E00032","unstructured":"Krumbholz M, Theil D, Cepok S, et al. Chemokines in multiple sclerosis: CXCL12 and CXCL13 up-regulation is differentially linked to CNS immune cell recruitment. <i>Brain.<\/i> 2006; 129:200-211."},{"key":"E00033","unstructured":"Rostasy K, Egles C, Chauhan A, et al. SDF-lalpha is expressed in astrocytes and neurons in the AIDS dementia complex: an in vivo and in vitro study. <i>J Neuropathol Exp Neural.<\/i> 2003; 62:617-626."},{"key":"E00034","doi-asserted-by":"crossref","unstructured":"Mazzucchelli L, Blaser A, Kappeler A, et al. BCA-1 is highly expressed in <i>Helicobacter pylori<\/i>\u2014induced mucosa-associated lymphoid tissue and gastric lymphoma. <i>J Clin Invest.<\/i> 1999; 104:R49-R54.","DOI":"10.1172\/JCI7830"},{"key":"E00035","unstructured":"Husson H, Freedman AS, Cardoso AA, et al. CXCL13 (BCA-1) is produced by follicular lymphoma cells: role in the accumulation of malignant B cells. <i>Br J Haematol.<\/i> 2002; 119:492-495."},{"key":"E00036","unstructured":"Mori M, Manuelli C, Pimpinelli N, et al. BCA-1, a B-cell chemoattractant signal, is constantly expressed in cutaneous lymphoproliferative B-cell disorders. <i>Eur J Cancer.<\/i> 2003; 39:1625-1631."},{"key":"E00037","unstructured":"Kimura R, Nishioka T, Ishida T. The SDF1-G801A polymorphism is not associated with <i>SDF1<\/i> gene expression in Epstein-Barr virus\u2014transformed lymphoblastoid cells. <i>Genes Immun.<\/i> 2003; 4:356-361."},{"key":"E00038","doi-asserted-by":"crossref","unstructured":"Hickey WF. Basic principles of immunological surveillance of the normal central nervous system. <i>Glia.<\/i> 2001; 36:118-124.","DOI":"10.1002\/glia.1101"},{"key":"E00039","unstructured":"Wu DT, Woodman SE, Weiss JM, et al. Mechanisms of leukocyte trafficking into the CNS. <i>J Neurovirol.<\/i> 2000; 6(suppl 1):S82-S85."},{"key":"E00040","unstructured":"Alter A, Duddy M, Hebert S, et al. Determinants of human B cell migration across brain endothelial cells. <i>J Immunol.<\/i> 2003; 170:4497-4505."},{"key":"E00041","unstructured":"Dunussi-Joannopoulos K, Zuberek K, Runyon K, et al. Efficacious immunomodulatory activity of the chemokine stromal cell-derived factor 1 (SDF-1): local secretion of SDF-1 at the tumor site serves as T-cell chemoattractant and mediates T-cell-dependent antitumor responses. <i>Blood.<\/i> 2002; 100:1551-1558."}],"container-title":["American Journal of Clinical Pathology"],"original-title":[],"language":"en","link":[{"URL":"http:\/\/academic.oup.com\/ajcp\/article-pdf\/127\/4\/633\/4988559\/ajcpath127-0633.pdf","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2019,4,26]],"date-time":"2019-04-26T23:15:56Z","timestamp":1556320556000},"score":1,"resource":{"primary":{"URL":"https:\/\/academic.oup.com\/ajcp\/article-lookup\/doi\/10.1309\/NUQHJ79BHWYD9TAF"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2007,4]]},"references-count":41,"journal-issue":{"issue":"4","published-online":{"date-parts":[[2007,4,1]]},"published-print":{"date-parts":[[2007,4]]}},"alternative-id":["10.1309\/NUQHJ79BHWYD9TAF"],"URL":"https:\/\/doi.org\/10.1309\/nuqhj79bhwyd9taf","relation":{},"ISSN":["0002-9173","1943-7722"],"issn-type":[{"value":"0002-9173","type":"print"},{"value":"1943-7722","type":"electronic"}],"subject":[],"published":{"date-parts":[[2007,4]]}}}